Skip to main content

Table 1 Baseline characteristics and biochemical parameters before and after PD

From: Peritoneal dialysis assists residual renal function to maintain glucose tolerance: a prospective observational study

Variables

ESRD (n = 20)

Non-diabetic

(n = 14)

Diabetic

(n = 6)

Age (years)

58.07 ± 12.85

58.17 ± 7.17

Sex (male/female)

11/3

6/0

BMI (kg/m2)

23.54 ± 2.90

29.76 ± 6.42

Antihypertensive agents

 ARB/ACE inhibitor

6 (42.86 %)

6 (100 %)

 Ca channel blocker

12 (85.71 %)

4 (66.67 %)

Hypoglycemic drugs

 Insulin

 

4 (66.67 %)

 Dpp-4 inhibitor

 

1 (16.67 %)

 Sulfonylurea

 

0 (0 %)

 α-GI

 

2 (33.33 %)

Biochemical parameters

Before PD

After PD

Before PD

After PD

 Total protein (mg/dL)

6.02 ± 0.98

6.39 ± 0.71*

5.60 ± 0.86

6.17 ± 0.50*

 Albumin (g/dL)

3.38 ± 0.75

3.43 ± 0.59

2.93 ± 0.62

3.15 ± 0.56

 BUN (mg/dL)

71.64 ± 16.70

53.08 ± 11.64**

67.47 ± 20.76

48.10 ± 12.62**

 Creatinine (mg/dL)

10.90 ± 3.93

9.96 ± 3.46*

10.50 ± 1.85

10.08 ± 2.21

 e-GFR (mL/min/1.73 m2)

4.89 ± 1.91

 

4.84 ± 1.39

 

 HbA1c (%)

5.33 ± 0.33

5.58 ± 0.39

6.22 ± 1.32

6.43 ± 1.25

 GA (%)

15.60 ± 4.18

16.90 ± 3.41

15.84 ± 2.78

16.20 ± 3.05

 WBC (103/μL)

6.38 ± 1.65

6.01 ± 1.14

7.85 ± 1.84

7.43 ± 1.45

 Hb (g/dL)

9.80 ± 1.08

10.40 ± 0.87

10.12 ± 0.87

11.08 ± 0.70*

 CRP (mg/dL)

0.14 ± 0.13

0.37 ± 0.63

0.52 ± 0.90

0.35 ± 0.46

  1. Results are shown as mean ± SD
  2. ESRD end-stage renal disease, BMI body mass index, ACE angiotensin-converting enzyme, ARB angiotensin-receptor blocker, Dpp-4 inhibitor dipeptidyl peptidase 4 inhibitor, α-GI α-glucosidase inhibitor, BUN blood urea nitrogen, e-GFR estimated glomerular filtration rate, HbA1c hemoglobin A1c, GA glycoalbumin, WBC white blood cell, Hb hemoglobin, CRP, C-reactive protein
  3. **p < 0.01 vs. before PD; *p < 0.05 vs. before PD
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us